Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17136209 | INDEL MARKER GENOTYPE DATABASE OF MALUS AND USE IN IDENTITY FINGERPRINTING OF GERMPLASM RESOURCES | December 2020 | October 2023 | Allow | 33 | 2 | 0 | No | No |
| 17253788 | PROGNOSTIC AND TREATMENT RESPONSE PREDICTIVE METHOD | December 2020 | May 2024 | Abandon | 41 | 1 | 0 | No | No |
| 17117471 | MAGNET ASSEMBLY TO PREVENT EXTRACTION PARTICLE CARRYOVER | December 2020 | December 2023 | Allow | 37 | 1 | 1 | No | No |
| 17113452 | INDEL DETECTION BY AMPLICON ANALYSIS | December 2020 | April 2024 | Abandon | 40 | 2 | 1 | No | No |
| 17113466 | DEVICES AND METHODS FOR PLASMID PURIFICATION | December 2020 | November 2023 | Abandon | 36 | 2 | 0 | No | No |
| 17059640 | Heater For Apparatus For Detecting Molecule(s) | November 2020 | March 2024 | Allow | 39 | 1 | 0 | No | No |
| 17102407 | SYSTEMS AND PROCESSES FOR DISTINGUISHING PATHOGENIC AND NON-PATHOGENIC SEQUENCES FROM SPECIMENS | November 2020 | October 2021 | Allow | 11 | 3 | 1 | Yes | No |
| 16954979 | POLYMERASE CHAIN REACTION COMPOSITION COMPRISING AMINES | November 2020 | June 2023 | Abandon | 36 | 2 | 0 | No | No |
| 17070796 | DE NOVO SURFACE PREPARATION AND USES THEREOF | October 2020 | August 2024 | Abandon | 46 | 3 | 0 | No | No |
| 17045474 | METHODS OF IDENTIFYING COMBINATIONS OF TRANSCRIPTION FACTORS | October 2020 | May 2023 | Allow | 32 | 1 | 0 | Yes | No |
| 17029711 | NANO-VESICLES DERIVED FROM GENUS CUPRIAVIDUS BACTERIA AND USE THEREOF | September 2020 | July 2023 | Allow | 34 | 1 | 1 | Yes | No |
| 16958233 | IDENTIFICATION OF WHITE LEGHORNS RED PLUMAGE MUTAGENIC MUTANT GENOTYPE AND CULTIVATION METHOD FOR SUPPORTING SYSTEM OF RED PLUMAGE PINK SHELL LAYER CHICKENS | September 2020 | April 2023 | Allow | 34 | 2 | 0 | No | No |
| 17018060 | METHODS OF SEQUENCING THE IMMUNE REPERTOIRE | September 2020 | December 2022 | Abandon | 27 | 1 | 0 | No | No |
| 17015702 | Biomarkers for the early detection of breast cancer | September 2020 | October 2022 | Allow | 25 | 2 | 1 | Yes | No |
| 17012280 | Micromechanical DNA Origami Force Sensor | September 2020 | March 2023 | Allow | 30 | 1 | 0 | No | No |
| 16971632 | Oligonucleotide, Set of Oligonucleotides, Method for Simultaneous Detection of Neisseria Meningitidis, Streptococcus Pneumoniae and Haemophilus Influenzae, and Kit | August 2020 | July 2023 | Abandon | 35 | 2 | 0 | No | No |
| 16965856 | RANDOM AMPLIFICATION METHODS FOR EXTREMELY LOW INPUT NUCLEIC ACIDS | July 2020 | August 2023 | Allow | 36 | 2 | 0 | Yes | No |
| 16964527 | PROXIMITY DETECTION METHODS AND COMPOSITIONS | July 2020 | January 2024 | Allow | 42 | 1 | 1 | No | No |
| 16928924 | COMPOSITIONS AND METHODS FOR MOLECULAR LABELING | July 2020 | June 2023 | Allow | 35 | 6 | 0 | No | No |
| 16925778 | RNA SEQUENCING METHODS | July 2020 | September 2022 | Allow | 26 | 0 | 1 | Yes | No |
| 16918365 | METHOD AND APPARATUS TO NORMALIZE QUANTITATIVE READOUTS IN SINGLE-CELL EXPERIMENTS | July 2020 | February 2023 | Allow | 31 | 2 | 0 | Yes | No |
| 16897052 | Compositions, Devices, Systems, and Methods for Using a Nanopore | June 2020 | April 2024 | Allow | 46 | 3 | 0 | Yes | No |
| 16892488 | MICROFLUIDIC ANALYSIS SYSTEM | June 2020 | June 2023 | Allow | 37 | 3 | 0 | Yes | No |
| 16888434 | NUCLEIC ACID SEQUENCING USING TAGS | May 2020 | July 2022 | Allow | 25 | 1 | 0 | No | No |
| 16887280 | FLEXIBLE AND HIGH-THROUGHPUT SEQUENCING OF TARGETED GENOMIC REGIONS | May 2020 | September 2021 | Allow | 15 | 2 | 1 | No | No |
| 16874177 | DETECTION OF DRUG RESISTANT MYCOBACTERIUM TUBERCULOSIS | May 2020 | August 2023 | Allow | 39 | 4 | 1 | Yes | No |
| 16762999 | METHOD FOR EXAMINING LONG-TERM PROGNOSIS OF ACUTE CORONARY SYNDROME AND DIAGNOSTIC KIT | May 2020 | September 2022 | Abandon | 29 | 1 | 0 | No | No |
| 16865262 | UNIVERSAL TEMPLATE STRANDS FOR ENZYMATIC POLYNUCLEOTIDE SYNTHESIS | May 2020 | April 2023 | Allow | 35 | 2 | 0 | Yes | No |
| 16759676 | Methods and Compositions for Treating Diseases Associated with Exhausted T Cells | April 2020 | October 2023 | Allow | 41 | 2 | 1 | Yes | No |
| 16758684 | FUNCTIONAL METAGENOMICS | April 2020 | July 2022 | Abandon | 26 | 0 | 1 | No | No |
| 16758190 | Mapping the Location, Type and Strand of Damaged and/or Mismatched Nucleotides in Double-Stranded DNA | April 2020 | March 2023 | Allow | 35 | 2 | 0 | No | No |
| 16848239 | METHODS AND DEVICES FOR ULTRASENSITIVE DIRECT DETECTION OF MICROORGANISMS | April 2020 | March 2023 | Allow | 35 | 1 | 1 | No | No |
| 16846663 | DETECTING NUCLEIC ACID | April 2020 | October 2021 | Allow | 18 | 1 | 0 | No | No |
| 16841892 | METHODS AND COMPOSITIONS FOR IDENTIFYING AND QUANTIFYING MICROBIAL DNA | April 2020 | October 2022 | Abandon | 30 | 2 | 0 | No | No |
| 16838800 | DIGITAL ANALYTE ANALYSIS | April 2020 | May 2022 | Allow | 25 | 2 | 0 | No | No |
| 16649234 | SINGLE MOLECULE SEQUENCING AND UNIQUE MOLECULAR IDENTIFIERS TO CHARACTERIZE NUCLEIC ACID SEQUENCES | March 2020 | January 2024 | Allow | 46 | 4 | 0 | Yes | No |
| 16812987 | METHODS AND DEVICES FOR DIGITAL PCR | March 2020 | February 2023 | Abandon | 35 | 3 | 0 | Yes | No |
| 16799424 | IN VITRO RECOMBINATION METHOD | February 2020 | August 2022 | Allow | 30 | 2 | 0 | No | No |
| 16795467 | COMPOSITIONS AND METHODS FOR MOLECULAR LABELING | February 2020 | July 2023 | Allow | 41 | 2 | 0 | No | No |
| 16782794 | NUCLEIC ACID AMPLIFICATION DEVICE, NUCLEIC ACID AMPLIFICATION METHOD, AND CHIP FOR NUCLEIC ACID AMPLIFICATION | February 2020 | June 2023 | Allow | 40 | 5 | 0 | No | No |
| 16633604 | METHODS OF ANTIGEN-DEPENDENT CHIMERIC ANTIGEN RECEPTOR (CAR) IMMUNE CELL SELECTION | January 2020 | August 2023 | Abandon | 43 | 2 | 0 | No | No |
| 16747737 | OLIGONUCLEOTIDES ASSOCIATED WITH ANTIBODIES | January 2020 | January 2023 | Allow | 36 | 4 | 1 | Yes | No |
| 16740355 | DE NOVO SURFACE PREPARATION AND USES THEREOF | January 2020 | August 2020 | Allow | 7 | 3 | 0 | Yes | No |
| 16739408 | GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISEASES, METHODS OF DETECTION AND USES THEREOF | January 2020 | April 2022 | Allow | 27 | 2 | 0 | No | No |
| 16736085 | COMPOSITIONS AND METHODS FOR GENOMIC DNA AND GENE EXPRESSION ANALYSIS IN SINGLE CELLS | January 2020 | March 2023 | Allow | 38 | 1 | 1 | No | No |
| 16735067 | NUCLEIC ACID SEQUENCES USING TAGS | January 2020 | January 2023 | Allow | 36 | 2 | 0 | Yes | No |
| 16730829 | NUCLEIC ACID ANALYSIS BY RANDOM MIXTURES OF NON-OVERLAPPING FRAGMENTS | December 2019 | April 2022 | Allow | 27 | 2 | 0 | No | No |
| 16722706 | SEQUENTIAL MULTIPLEX WESTERN BLOTTING | December 2019 | December 2022 | Abandon | 36 | 1 | 0 | No | No |
| 16719744 | POLYNUCLEOTIDES FOR THE AMPLIFICATION AND DETECTION OF NEISSERIA GONORRHOEAE | December 2019 | November 2020 | Allow | 11 | 2 | 1 | No | No |
| 16623975 | MESYLATE BASED MASTER MIX | December 2019 | December 2021 | Allow | 24 | 2 | 0 | No | No |
| 16716952 | Method of Marking Cellulosic Products | December 2019 | September 2021 | Allow | 21 | 1 | 0 | No | No |
| 16693983 | SAMPLE PREPARATION DEVICE AND METHODS OF USE | November 2019 | July 2021 | Allow | 20 | 1 | 0 | No | No |
| 16690525 | METHODS AND PROBES FOR PERFORMING PCR WITH MELT ANALYSIS FOR INCREASED MULTIPLEXING | November 2019 | March 2022 | Allow | 27 | 1 | 0 | No | No |
| 16615645 | IMPROVEMENTS IN THE RECOVERY OF NUCLEIC ACIDS FROM SOLID SUPPORTS | November 2019 | September 2023 | Allow | 46 | 4 | 0 | Yes | No |
| 16603061 | METHODS OF DETECTING LUNG CANCER | October 2019 | August 2022 | Allow | 34 | 1 | 1 | No | No |
| 16493874 | METHODS FOR IDENTIFYING AND MONITORING PREGNANT WOMEN AT RISK OF PREECLAMPSIA | September 2019 | July 2023 | Allow | 46 | 3 | 0 | Yes | No |
| 16492076 | NUCLEIC ACID SEQUENCING-BY-SYNTHESIS (SBS) METHODS THAT COMBINE SBS CYCLE STEPS | September 2019 | November 2022 | Allow | 38 | 3 | 0 | No | No |
| 16563594 | NANO-VESICLES DERIVED FROM GENUS CUPRIAVIDUS BACTERIA AND USE THEREOF | September 2019 | November 2020 | Abandon | 14 | 2 | 0 | No | No |
| 16555803 | IMAGE DRIVEN QUALITY CONTROL FOR ARRAY-BASED PCR | August 2019 | July 2023 | Allow | 47 | 1 | 0 | No | No |
| 16553040 | EFFICIENT OPTICAL ANALYSIS OF POLYMERS USING ARRAYS OF NANOSTRUCTURES | August 2019 | February 2021 | Allow | 18 | 0 | 0 | No | No |
| 16487697 | KIT FOR DETECTING SILENT SEXUALLY TRANSMITTED DISEASES (SSTDS) IN A URINE SAMPLE | August 2019 | December 2022 | Allow | 40 | 2 | 0 | No | No |
| 16484461 | METHOD FOR LABEL-FREE SINGLE-MOLECULE DNA SEQUENCING AND DEVICE FOR IMPLEMENTING SAME | August 2019 | February 2021 | Allow | 60 | 3 | 1 | Yes | No |
| 16523609 | POLYNUCLEOTIDES FOR THE AMPLIFICATION AND DETECTION OF NEISSERIA GONORRHOEAE | July 2019 | June 2020 | Abandon | 11 | 1 | 0 | No | No |
| 16516808 | METHODS AND COMPOSITIONS FOR STABILIZING NUCLEIC ACID-NUCLEOTIDE-POLYMERASE COMPLEXES | July 2019 | October 2021 | Allow | 27 | 2 | 0 | No | No |
| 16472734 | METHOD AND DEVICE FOR DIGITAL HIGH RESOLUTION MELT | June 2019 | December 2023 | Allow | 53 | 4 | 0 | Yes | No |
| 16437512 | Characteristic sequence, labeled primer and identification method of Carya illinoensis variety davis | June 2019 | September 2022 | Allow | 40 | 2 | 0 | No | No |
| 16430007 | METHOD FOR DETECTING CHIKUNGUNYA VIRUS | June 2019 | July 2021 | Abandon | 25 | 1 | 0 | No | No |
| 16421284 | THIOLATED NUCLEOTIDE ANALOGUES FOR NUCLEIC ACID SYNTHESIS | May 2019 | February 2021 | Allow | 21 | 1 | 0 | No | No |
| 16418104 | COMPOSITIONS AND METHODS FOR IDENTIFYING NUCLEIC ACID MOLECULES | May 2019 | February 2021 | Allow | 21 | 3 | 0 | Yes | No |
| 16461981 | COMPOSITIONS AND METHODS FOR ABSOLUTE QUANTIFICATION OF REVERSE TRANSCRIPTASE ENZYMES | May 2019 | September 2022 | Abandon | 40 | 2 | 0 | No | No |
| 16415815 | METHOD FOR IDENTIFYING THE SOURCE OF AN AMPLICON | May 2019 | May 2021 | Abandon | 24 | 1 | 0 | No | No |
| 16349250 | THERAPEUTIC OLIGONUCLEOTIDES CAPTURE AND DETECTION | May 2019 | February 2023 | Abandon | 45 | 2 | 1 | Yes | No |
| 16408970 | SYSTEMS AND METHODS FOR ANALYZING RNA TRANSCRIPTS | May 2019 | September 2023 | Abandon | 52 | 2 | 0 | No | No |
| 16404583 | NUCLEIC ACID AMPLIFICATION PRIMERS FOR PCR-BASED CLONALITY STUDIES | May 2019 | May 2021 | Abandon | 25 | 0 | 1 | No | No |
| 16400858 | COMPOSITIONS AND METHODS FOR MOLECULAR LABELING | May 2019 | August 2021 | Allow | 28 | 5 | 0 | No | No |
| 16380584 | METHODS FOR DETECTING TARGET ANALYTES | April 2019 | May 2021 | Allow | 25 | 1 | 0 | No | No |
| 16355361 | METHODS AND COMPOSITIONS FOR STABILIZING NUCLEIC ACID-NUCLEOTIDE-POLYMERASE COMPLEXES | March 2019 | July 2019 | Allow | 4 | 0 | 0 | No | No |
| 16296435 | METHODS OF PREDICTING MORTALITY RISK BY DETERMINING TELOMERE LENGTH | March 2019 | July 2021 | Allow | 29 | 2 | 0 | No | No |
| 16330357 | CONTROLLING FLUORESCENT SIGNAL COMPOSITION IN OPTICALLY-BASED NANOPORE SEQUENCING | March 2019 | July 2022 | Allow | 41 | 3 | 0 | Yes | No |
| 16330352 | METHODS FOR LABELLING NUCLEIC ACIDS | March 2019 | February 2022 | Allow | 35 | 1 | 0 | No | No |
| 16289324 | METHOD OF PREPARING CLINICAL SAMPLES FOR NUCLEIC ACID AMPLIFICATION | February 2019 | September 2019 | Allow | 7 | 1 | 0 | Yes | No |
| 16258021 | METHOD FOR SYNTHESIZING SELECTIVELY LABELED RNA | January 2019 | April 2021 | Allow | 27 | 1 | 0 | No | No |
| 16253898 | METHODS FOR ASSEMBLING AND READING NUCLEIC ACID SEQUENCES FROM MIXED POPULATIONS | January 2019 | May 2021 | Abandon | 28 | 1 | 0 | No | No |
| 16319264 | METHODS FOR DISCRIMINATING A TOLERANT SUBJECT | January 2019 | June 2022 | Allow | 41 | 1 | 0 | No | No |
| 16242695 | DETECTING CHOLANGIOCARCINOMA | January 2019 | September 2020 | Allow | 20 | 1 | 0 | Yes | No |
| 16227732 | Nucleic Acid Amplification Controls and Kits and Methods of Use Thereof | December 2018 | March 2023 | Allow | 51 | 6 | 0 | No | No |
| 16206253 | SINGLE-SIDED HEAT TRANSFER INTERFACE FOR A DIAGNOSTIC ASSAY SYSTEM | November 2018 | August 2023 | Abandon | 57 | 5 | 0 | Yes | No |
| 16204642 | PROCESS FOR MICROSATELLITE INSTABILITY DETECTION | November 2018 | October 2022 | Allow | 46 | 7 | 0 | Yes | No |
| 16303441 | SYSTEM AND METHOD FOR OPTIMIZING HEAT TRANSFER FOR TARGET AMPLIFICATION WITHIN A DIAGNOSTIC ASSAY SYSTEM | November 2018 | January 2024 | Abandon | 60 | 7 | 0 | Yes | No |
| 16194552 | Method for Fragmenting DNA by Nick Translation | November 2018 | April 2021 | Allow | 29 | 1 | 0 | Yes | No |
| 16193916 | Rare Cell Analysis Using Sample Splitting And DNA Tags | November 2018 | November 2021 | Allow | 36 | 5 | 0 | No | No |
| 16189259 | METHODS OF DIAGNOSING AND TREATING CANCER BY DETECTING AND MANIPULATING MICROBES IN TUMORS | November 2018 | April 2021 | Abandon | 29 | 1 | 0 | No | No |
| 16300469 | Compositions and Methods for Identifying, Quantifying, and/or Characterizing an Analyte | November 2018 | October 2021 | Allow | 36 | 2 | 0 | No | No |
| 16180290 | METHOD FOR GENERATING HIGH AFFINITY, BIVALENT BINDING AGENTS FOR SANDWICH ASSAYS | November 2018 | July 2022 | Allow | 44 | 4 | 0 | No | No |
| 16171675 | UNIVERSAL SANGER SEQUENCING FROM NEXT-GEN SEQUENCING AMPLICONS | October 2018 | April 2021 | Allow | 29 | 2 | 0 | No | No |
| 16155729 | SINGLE MOLECULE SEQUENCING AND UNIQUE MOLECULAR IDENTIFIERS TO CHARACTERIZE NUCLEIC ACID SEQUENCES | October 2018 | September 2019 | Abandon | 12 | 1 | 0 | No | No |
| 16144742 | METHOD OF QUANTIFYING HIV RESERVOIRS BY INDUCED TRANSCRIPTION BASED SEQUENCING | September 2018 | November 2022 | Allow | 50 | 2 | 0 | No | No |
| 16136498 | METHOD OF DETECTING ANALYTE IN A SAMPLE WITH BINDING REAGENT, FIRST DETECTION REAGENT, AND SECOND DETECTION REAGENT | September 2018 | February 2023 | Allow | 53 | 3 | 1 | Yes | No |
| 16130656 | Multiplex Detection of Short Nucleic Acids | September 2018 | October 2022 | Allow | 49 | 2 | 0 | No | No |
| 16129206 | DATA PROCESSING, ANALYSIS METHOD OF GENE EXPRESSION DATA TO IDENTIFY ENDOGENOUS REFERENCE GENES | September 2018 | May 2021 | Allow | 32 | 2 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner WOOLWINE, SAMUEL C.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 8.9% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner WOOLWINE, SAMUEL C works in Art Unit 1637 and has examined 719 patent applications in our dataset. With an allowance rate of 51.7%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 39 months.
Examiner WOOLWINE, SAMUEL C's allowance rate of 51.7% places them in the 15% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by WOOLWINE, SAMUEL C receive 2.35 office actions before reaching final disposition. This places the examiner in the 63% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by WOOLWINE, SAMUEL C is 39 months. This places the examiner in the 25% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +27.4% benefit to allowance rate for applications examined by WOOLWINE, SAMUEL C. This interview benefit is in the 74% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 15.7% of applications are subsequently allowed. This success rate is in the 14% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 42.3% of cases where such amendments are filed. This entry rate is in the 66% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 33.3% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 33% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 47% percentile among all examiners. Of these withdrawals, 81.2% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 67.6% are granted (fully or in part). This grant rate is in the 74% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 2.8% of allowed cases (in the 79% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 14.0% of allowed cases (in the 92% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.